Cochlear has introduced the Osia 3 Sound Processor in the United States after receiving U.S. FDA clearance for the latest generation of its active bone conduction hearing system.
The Osia system is designed for children and adults with conductive hearing loss, mixed hearing loss and single-sided deafness. The new processor builds on Cochlear’s implantable hearing portfolio, with improvements focused on daily usability, sound quality and connected care.
This is relevant because hearing loss management increasingly depends on devices that fit into daily life, not only devices that restore auditory access. Battery handling, streaming compatibility, remote adjustments and sound quality can all influence long-term use and patient satisfaction.
The Osia 3 Sound Processor is positioned as the first fully rechargeable active bone conduction sound processor in its class. Cochlear said it provides up to 30 hours of hearing on a single charge, with an on-the-go charging case that can hold additional charges.
The shift away from disposable batteries may improve convenience for users and reduce recurring battery-handling burden, especially for patients who use their processor throughout the day. It may also support sustainability by reducing disposable battery waste.
The device includes the new Zaphium signal processing chip, which offers a wider frequency bandwidth than the previous generation. It also includes ForwardFocus technology, designed to help users focus on speech and reduce background noise in complex listening environments.
Clinical research cited by the company reported that recipients preferred the sound quality of the Osia 3 Sound Processor over the previous generation, with 97 per cent of recipients satisfied or very satisfied with overall sound quality.
Connectivity is another differentiator. The processor supports streaming from Apple, Android and Bluetooth LE Audio-enabled devices, and is compatible with Auracast broadcast audio as the ecosystem develops. This could improve access to shared audio in public spaces such as cinemas, airports and lecture halls.
The product also supports remote care functions. Osia Fitting Software 3 enables Remote Care compatibility, wireless fitting and improved data logging, allowing certain follow-up adjustments to be conducted through secure video appointments where clinically appropriate.
The Osia 3 Sound Processor is backward-compatible for eligible existing Osia System users, depending on their implant model. This is commercially important because upgrade pathways can support adoption among existing users without requiring a new implant.
Cochlear said the Osia 3 Sound Processor will be available in the United States in early fall, with availability in other countries subject to regulatory approval.
